A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
Clinical trial NCT05861999 · RECRUITING
Trial details
- NCT number
- NCT05861999
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-14
- Primary completion
- 2028-03-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.